Abstract:Patient-derived cancer cells (PDCs) and patient-derived xenografts (PDXs) are often used as tumor models, but have many shortcomings. PDCs not only lack diversity in terms of cell type, spatial organization, and microenvironment but also have adverse effects in stem cell cultures, whereas PDX are expensive with a low transplantation success rate and require a long culture time. In recent years, advances in three-dimensional (3D) organoid culture technology have led to the development of novel physiological systems that model the tissues of origin more precisely than traditional culture methods. Patient-derived cancer organoids bridge the conventional gaps in PDC and PDX models and closely reflect the pathophysiological features of natural tumorigenesis and metastasis, and have led to new patient-specific drug screening techniques, development of individualized treatment regimens, and discovery of prognostic biomarkers and mechanisms of resistance. Synergistic combinations of cancer organoids with other technologies, for example, organ-on-a-chip, 3D bio-printing, and CRISPR-Cas9-mediated homology-independent organoid transgenesis, and with treatments, such as immunotherapy, have been useful in overcoming their limitations and led to the development of more suitable model systems that recapitulate the complex stroma of cancer, inter-organ and intra-organ communications, and potentially multiorgan metastasis. In this review, we discuss various methods for the creation of organ-specific cancer organoids and summarize organ-specific advances and applications, synergistic technologies, and treatments as well as current limitations and future prospects for cancer organoids. Further advances will bring this novel 3D organoid culture technique closer to clinical practice in the future.

Opportunities and challenges of hepatocellular carcinoma organoids for targeted drugs sensitivity screening

Emerging Biomolecules for Practical Theranostics of Liver Hepatocellular Carcinoma.

Human Hepatobiliary Organoids: Recent Advances in Drug Toxicity Verification and Drug Screening

Liver organoids and their application in liver cancer research

Integrated Characterization of Hepatobiliary Tumor Organoids Provides a Potential Landscape of Pharmacogenomic Interactions

Organoid As a Promising Tool for Primary Liver Cancer Research: a Comprehensive Review

Drug delivery strategy in hepatocellular carcinoma therapy

Hepatocellular-Carcinoma-Derived Organoids: Innovation in Cancer Research

Drug screening model meets cancer organoid technology

Primary liver cancer organoids and their application to research and therapy

Progress, Application and Challenges of Liver Organoids

Development of Liver Cancer Organoids: Reproducing Tumor Microenvironment and Advancing Research for Liver Cancer Treatment

Organoids: opportunities and challenges of cancer therapy

Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy

Updates on Organoid Model for the Study of Liver Cancer

Liver organoids: a promising three-dimensional model for insights and innovations in tumor progression and precision medicine of liver cancer

The application of pancreatic cancer organoids for novel drug discovery

Advancing cancer research through organoid technology

Targeted Drug Delivery Strategies for the Treatment of Hepatocellular Carcinoma

[Application and research progress of patient-derived organoids in the multimodality treatment of pancreatic cancer]

Cancer organoids: A platform in basic and translational research